A conversation with Seyed Mortazavi, IMS Health
Investor group calls on biotech manufacturers' boards to be more forthright on biosimilars
PBM formulary exclusion lists continue to grow
Catalent goes public in a successful IPO
EvaluatePharma forecast: 2020 global pharma sales of $1.107 trillion
Agency rides the rare-disease wave
Lifecycle solutions: aiming for better patient outcomes through high-quality prefillable solutions
Legal uncertainties in the DSCSA
Is tech running you? Four ways to retake control
Pharma brand teams need to reset their patient-journey analysis, says IMS Consulting
Pharma rep access: down, down, down
CVS/pharmacy earns URAC accreditation for 'community pharmacy'
For pharma, it's getting harder and harder to follow the money
Envirotainer wins FAA approval for its cold-chain containers on US air freighters
Converging the pharma business with its logistics and data functions